Subscribe for the Newsletter

Mobile Navigation

Company Info

Sio Gene Therapies

Sio Gene Therapies

Drug Discovery & Development

Overview

Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson’s disease.

Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.

Sio Gene Therapies
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.